MicuRx Pharmaceuticals signed a strategic cooperation agreement with Haiqing Pharmaceuticals

MicuRx Pharmaceuticals has signed a strategic cooperation agreement with Nanjing Haiqing Pharmaceuticals. The two parties will collaborate in areas such as market and customer network, and service value enhancement. The goal is to integrate market resources to promote the sales of the company's products in new regions and hospitals, with expected sales revenues of 260 million yuan, 388 million yuan, and 600 million yuan for the years 2026-2028, respectively. The two parties will also establish a product innovation cooperation platform, focusing on research in disease prevention and treatment, jointly developing new products, and promoting the internationalization of Chinese pharmaceutical companies